1. MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications
    Fatemeh Hosseinpour-Soleimani et al, 2024, Heliyon CrossRef
  2. COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments
    Irina Gilyazova et al, 2023, Non-coding RNA Research CrossRef
  3. Neutrophil elastase decreases SARS-CoV-2 spike protein binding to human bronchial epithelia by clipping ACE-2 ectodomain from the epithelial surface
    Apparao B. Kummarapurugu et al, 2023, Journal of Biological Chemistry CrossRef
  4. MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response
    Tânia R. Dias et al, 2022, Cells CrossRef
  5. Evaluation of MicroRNA Expression Pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU and Diabetic COVID-19 Patients
    AliReza Khatami et al, 2023, Intervirology CrossRef
  6. miRNA expression in COVID-19
    Kiarash Roustai Geraylow et al, 2022, Gene Reports CrossRef
  7. Revisiting Inhibition Effects of miR-28 as a Metastasis Suppressor in Gastrointestinal Cancers
    Saiedeh Razi Soofiyani et al, 2023, MicroRNA CrossRef
  8. MiR-145–5p reduced ANG II-induced ACE2 shedding and the inflammatory response in alveolar epithelial cells by targeting ADAM17 and inhibiting the AT1R/ADAM17 pathway
    Xu'an Wang et al, 2024, European Journal of Pharmacology CrossRef
  9. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
    Christian A. Devaux et al, 2022, Frontiers in Microbiology CrossRef